On March 18th, at the 8th E-Trade Bioindustry Conference of 2023EBC, MGI Tech held the "DNBSEQ-G99 Signing Ceremony" and reached cooperation with 6 enterprise partners to develop G99-based application expansion.

At the signing ceremony, on behalf of the company, Ma Tao, Assistant President of Marketing System of MGI Tech Headquarters, signed cooperation agreements with Liang Yinlong, President of Chengge Medical Inspection, Guo Zongliang, Purchasing Director of Dinfectome Medical Technology, Ding Qingyu, General Manager of Haibe Gene, Zhang Zhihong, Chief Technical Officer of Burning Rock Biotech, Xu Zhuofei, CTO of GENOXOR, and Zhou Qihao, Vice President of Marketing of Yeasen Biotechnology (in alphabetical order of the company), which will together promote the application of DNBSEQ-G99 in the fields of tumor precision medicine, pathogenic microbial detection, scientific and technological services, and reproductive health, to create life science industry ecology and promote the development of life science industry.

The DNBSEQ-G99 has a dual carrier, capable of running two carriers at the same time, and can run two rounds of PE150 sequencing in one day. The DNBSEQ-G99 can support sequencing modes from SE35 to PE150, which makes it easier to cope with sequencing needs at different time points and different read lengths with full efficiency and a wide range of applications.